Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 48.93 |
| Open | 49.00 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's Range | 48.87 - 49.56 |
| 52 Week Range | 47.58 - 70.94 |
| Volume | |
| Avg. Volume | 15,525,840 |
| Market Cap | 99.595B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 12.73 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.40 (4.88%) |
| Ex-Dividend Date | Apr 04, 2024 |
| 1y Target Est | N/A |
- Zacks
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Investors are likely to focus on Opdivo's demand, along with an incremental contribution from newer drugs, when Bristol-Myers (BMY) posts Q1 results.
- Zacks
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of Bristol Myers (BMY) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- Simply Wall St.
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
© 2024 Yahoo. All rights reserved.